Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.73 |
| ▸ | RAB9A | P51151 | 3/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.73 |
| ▸ | MAOB | P27338 | 8/20 | 0.71 |
| ▸ | MAOA | P21397 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11350421 | 0.93 | RAB9A (0.82) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL10236929 | 0.93 | RAB9A (0.82) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL12086470 | 0.89 | RAB9A (0.80) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL3729907 | 0.89 | NPC1 (0.75) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL11363883 | 0.87 | RAB9A (0.73) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL898771 | 0.87 | RXRA (0.77) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL933577 | 0.87 | MAOB (0.76) | NPC1RAB9ASMN1; SMN2MAPTMAOB | |
| SCHEMBL18569721 | 0.86 | LOXL2 (0.75) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL6326840 | 0.86 | RAB9A (0.71) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL254368 | 0.86 | NPC1 (0.71) | NPC1RAB9ASMN1; SMN2MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114075187-B | Carbonyl pyrazole antitumor compound as well as preparation method and application thereof | 山东大学 | 2023-05-12 | — | — | CN | disclosed |
| CN-114075187-A | Carbonyl pyrazole anti-tumor compound and preparation method and application thereof | 山东大学 | 2022-02-22 | — | — | CN | disclosed |
| EP-0729465-B1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE DAVIS & CO (US) | 2003-01-22 | — | — | EP | disclosed |
| US-6005103-A | TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS | WARNER-LAMBERT COMPANY (US) | 1999-12-21 | — | — | US | disclosed |
| EP-0729465-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995014013-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1995-05-26 | — | — | WO | disclosed |